Literature DB >> 20615979

Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes.

Jeremy A Ryan1, Joslyn K Brunelle, Anthony Letai.   

Abstract

It is well established that CD4(+) CD8(+) thymocytes are more sensitive to myriad death stimuli than CD4(+) or CD8(+) single positive (SP) thymocytes. The mechanism behind this hypersensitivity to apoptosis of CD4(+) CD8(+) thymocytes is not understood. To test whether the difference lay in the apoptotic preset of mitochondria, established by the BCL-2 family of proteins, we developed a method, FACS-based BH3 profiling. Using this tool, we could discriminate thymocyte subpopulations and demonstrate that mitochondria in double positive (DP) thymocytes are more primed for death than those in single positive counterparts. Loss of proapoptotic BIM, known to cause autoimmunity, also causes loss of "priming." Priming is a phenotype with physiologic consequences, which can be measured at the single-cell level in complex samples using FACS-based BH3 profiling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615979      PMCID: PMC2919900          DOI: 10.1073/pnas.0914878107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The expanding role of mitochondria in apoptosis.

Authors:  X Wang
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

Review 2.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells.

Authors:  Yanan Zhu; Bradley J Swanson; Michael Wang; David A Hildeman; Brian C Schaefer; Xinqi Liu; Hiroyuki Suzuki; Katsuyoshi Mihara; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

4.  Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis.

Authors:  Naoufal Zamzami; Guido Kroemer
Journal:  Methods Mol Biol       Date:  2004

5.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

6.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

Authors:  A Strasser; A W Harris; S Cory
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

7.  bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.

Authors:  J Gratiot-Deans; L Ding; L A Turka; G Nuñez
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

8.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

9.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

10.  Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain.

Authors:  Jean-Ehrland Ricci; Cristina Muñoz-Pinedo; Patrick Fitzgerald; Béatrice Bailly-Maitre; Guy A Perkins; Nagendra Yadava; Immo E Scheffler; Mark H Ellisman; Douglas R Green
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

View more
  84 in total

Review 1.  Targeting the B-cell lymphoma/leukemia 2 family in cancer.

Authors:  Matthew S Davids; Anthony Letai
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.

Authors:  S Colak; C D Zimberlin; E Fessler; L Hogdal; P R Prasetyanti; C M Grandela; A Letai; J P Medema
Journal:  Cell Death Differ       Date:  2014-03-28       Impact factor: 15.828

3.  Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

Authors:  Joan Montero; Kristopher A Sarosiek; Joseph D DeAngelo; Ophélia Maertens; Jeremy Ryan; Dalia Ercan; Huiying Piao; Neil S Horowitz; Ross S Berkowitz; Ursula Matulonis; Pasi A Jänne; Philip C Amrein; Karen Cichowski; Ronny Drapkin; Anthony Letai
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 4.  Mitochondria: gatekeepers of response to chemotherapy.

Authors:  Kristopher A Sarosiek; Triona Ni Chonghaile; Anthony Letai
Journal:  Trends Cell Biol       Date:  2013-09-21       Impact factor: 20.808

5.  Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Kazuyuki Murase; Haesook T Kim; O R Gregory Bascug; Yutaka Kawano; Jeremy Ryan; Ken-ichi Matsuoka; Matthew S Davids; John Koreth; Vincent T Ho; Corey Cutler; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Anthony Letai; Jerome Ritz
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

Review 6.  BCL-2 inhibition in AML: an unexpected bonus?

Authors:  Marina Konopleva; Anthony Letai
Journal:  Blood       Date:  2018-07-23       Impact factor: 22.113

7.  BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia.

Authors:  William E Pierceall; Steven M Kornblau; Nicole E Carlson; Xuelin Huang; Noel Blake; Ryan Lena; Michael Elashoff; Marina Konopleva; Michael H Cardone; Michael Andreeff
Journal:  Mol Cancer Ther       Date:  2013-10-03       Impact factor: 6.261

Review 8.  Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer.

Authors:  Sarah R Walker; Michael Xiang; David A Frank
Journal:  Mol Cell Endocrinol       Date:  2013-03-24       Impact factor: 4.102

9.  Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.

Authors:  Timothy G Whitsett; Ian T Mathews; Michael H Cardone; Ryan J Lena; William E Pierceall; Michael Bittner; Chao Sima; Janine LoBello; Glen J Weiss; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2014-01-27       Impact factor: 5.852

10.  B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.

Authors:  Thibaud T Renault; Rana Elkholi; Archana Bharti; Jerry E Chipuk
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.